Home Blog Pharmaceutical Litigation

Pharmaceutical Litigation

1 2 3
Are You the Victim of a Stryker Hip Implant?

Are You the Victim of a Stryker Hip Implant?

| Pharmaceutical Litigation
Stryker hip implants are artificial joints that are designed to resemble a normal, healthy joint. Designed for those people who are experiencing debilitating pain in the hip, which cannot be relieved through other methods, including physical therapy and corticosteroid injections, Stryker hip implants are used in invasive hip replacement surgeries. While some implant procedures may…Read the article
Opioid Epidemic: A Crisis Many Americans Struggle With

Opioid Epidemic: A Crisis Many Americans Struggle With

| Pharmaceutical Litigation
In 2015, the opioid epidemic in America took the lives of more than 33,000 people. These people come from all backgrounds and income levels, races and family types. Today, opioid overdosing kills nearly as many people as do car accidents, and heroin deaths alone kill more people than do gun homicides. What’s Fueling the Opioid…Read the article
Abilify: Link to Compulsive Gambling

Abilify: Link to Compulsive Gambling

| Pharmaceutical Litigation
Abilify is one of the top-selling antipsychotic drugs in the United States and is often used to treat bipolar disorder, schizophrenia, and Tourette’s syndrome. However, the drug may be dangerous and lead to compulsive and risky behaviors. Many people who have taken Abilify have filed suit against the drug’s makers, Otsuka and Bristol-Myers Squibb,  alleging…Read the article
Partner Jennifer Liakos Named to Abilify Plaintiffs’ Steering Committee

Partner Jennifer Liakos Named to Abilify Plaintiffs’ Steering Committee

| Pharmaceutical Litigation
Congratulations Napoli Shkolnik partner Jennifer R. Liakos for being appointed on the Plaintiffs’ Steering Committee in the In re Abilify (Aripiprazole)) Products Liability Litigation (Case No. 3:16-md02734) by Chief United States District Judge M. Casey Rodgers. The Order states there were many applications for this multi-district litigation (MDL); however, the Court appointed the MDL leadership…Read the article
New York Law Journal and The Recorder Front Pages Highlights Napoli Shkolnik PLLC Litigation

New York Law Journal and The Recorder Front Pages Highlights Napoli Shkolnik PLLC Litigation

| Pharmaceutical Litigation
As was reported by Tony Mauro of the NYLJ and Ben Hancock of The Recorder, personal jurisdiction cases are a hot issue right now, with four cases pending before the U.S. Supreme Court. In the Bristol-Myers case, the California Supreme Court ruled that both in-state and out-of-state plaintiffs could sue the pharmaceutical company in California…Read the article
NYLJ Reports: J&J Knew Cancer Risks Associated with Talc-Based Products

NYLJ Reports: J&J Knew Cancer Risks Associated with Talc-Based Products

| Pharmaceutical Litigation
Johnson & Johnson has known about the increased ovarian cancer risk associated with the use of their talc-based products but failed to warn women who used it. In fact, the supposed family friendly company did nothing, not even putting a warning label on the box despite the numerous research studies showing the connection between talcum…Read the article
Law360 Recognizes Napoli Shkolnik Litigation As A Top Product Liability Case of 2016

Law360 Recognizes Napoli Shkolnik Litigation As A Top Product Liability Case of 2016

| Pharmaceutical Litigation
Law360 Publishes Year-End Report: Recognizes Napoli Shkolnik PLLC Litigation As One of the Top Product Liability Cases of 2016 Law360 Reviews the most significant product liability ruling of the past year. Law360 has assembled a list of the top Product Liability Cases of 2016 in their Year-End Report and has named Bristol-Myers Squibb Co. v.…Read the article
Medtronic Recalls Neurovascular Products

Medtronic Recalls Neurovascular Products

| Pharmaceutical Litigation
Manufacturer Medtronic plc has recalled (officially October 5, 2016) several of its products due to potential separation and detachment of the PTFE coating. The PTFE coating is meant to reduce the friction and ease the navigation between the devices but if it separates from the device it could enter the blood stream of the patient. Separated…Read the article
Hunter Shkolnik Quoted in ALM/Texas Lawyer About Chemo Drug

Hunter Shkolnik Quoted in ALM/Texas Lawyer About Chemo Drug

| Pharmaceutical Litigation
UPDATE: Hunter Shkolnik has been appointed to the Taxotere Products Liability Litigation Plaintiffs’ Steering Committee by United States District Judge, Kurt D. Engelhardt Partner Hunter Shkolnik submitted an application for lead counsel appointment consideration in the Taxotere chemotherapy drug liability multi-district litigation. There has been an unusually large number of plaintiff attorney submissions with more…Read the article
Hunter Shkolnik Quoted in Healthline Regarding Plavix Lawsuit

Hunter Shkolnik Quoted in Healthline Regarding Plavix Lawsuit

| Pharmaceutical Litigation
As was recently reported, the California Supreme Court ruled that eight Plavix product liability lawsuits against manufacturer Bristol-Myers Squibb and distributor McKesseon Corporation can proceed in San Francisco Superior Court. Plavix (clopidogrel) is a blood thinner used to reduce the risk of blood clots and is prescribed to people who are at a higher risk…Read the article
1 2 3

Contact Us

Get a free case evaluation Attorney Referral

For all other inquiry types, please Contact Us or call (844) 230-7676